Interpace Biosciences Buy Hold or Sell Recommendation

IDXGDelisted Stock  USD 2.20  0.00  0.00%   
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Interpace Biosciences is 'Not Rated'. Macroaxis provides Interpace Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IDXG positions.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
Note, we conduct extensive research on individual companies such as Interpace and provide practical buy, sell, or hold advice based on investors' constraints. Interpace Biosciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.

Execute Interpace Biosciences Buy or Sell Advice

The Interpace recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Interpace Biosciences. Macroaxis does not own or have any residual interests in Interpace Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Interpace Biosciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Interpace BiosciencesBuy Interpace Biosciences
Not Rated
For the selected time horizon Interpace Biosciences has a Risk Adjusted Performance of 0.103, Jensen Alpha of 2.87, Total Risk Alpha of (1.01), Sortino Ratio of 0.2065 and Treynor Ratio of (2.23)
We provide advice to complement the regular expert consensus on Interpace Biosciences. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Interpace Biosciences is not overpriced, please check out all Interpace Biosciences fundamentals, including its ebitda, earnings per share, z score, as well as the relationship between the debt to equity and total asset . Please also validate Interpace Biosciences price to earning to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Interpace Biosciences Trading Alerts and Improvement Suggestions

Interpace Biosciences is not yet fully synchronised with the market data
Interpace Biosciences has a very high chance of going through financial distress in the upcoming years
Interpace Biosciences currently holds 9.44 M in liabilities with Debt to Equity (D/E) ratio of 6.55, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Interpace Biosciences has a current ratio of 0.6, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Interpace Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Interpace Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Interpace Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Interpace to invest in growth at high rates of return. When we think about Interpace Biosciences' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 41.31 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 17.95 M.
Interpace Biosciences currently holds about 1.86 M in cash with (8.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Roughly 28.0% of Interpace Biosciences shares are held by company insiders

Interpace Biosciences Returns Distribution Density

The distribution of Interpace Biosciences' historical returns is an attempt to chart the uncertainty of Interpace Biosciences' future price movements. The chart of the probability distribution of Interpace Biosciences daily returns describes the distribution of returns around its average expected value. We use Interpace Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Interpace Biosciences returns is essential to provide solid investment advice for Interpace Biosciences.
Mean Return
2.73
Value At Risk
-16.19
Potential Upside
18.81
Standard Deviation
22.35
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Interpace Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Interpace Biosciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Interpace . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Interpace Biosciences Buy or Sell Advice

When is the right time to buy or sell Interpace Biosciences? Buying financial instruments such as Interpace OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Interpace Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Value Funds Thematic Idea Now

Small Value Funds
Small Value Funds Theme
Funds or Etfs that invest in the undervalued stocks of small to mid-sized companies. The Small Value Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Value Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Interpace OTC Stock

If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing